pyrrolidine dithiocarbamate has been researched along with Endometrioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydin, NE; Celik, O; Elter, K; Gurates, B; Hascalik, S; Tagluk, ME | 1 |
| Cvek, B | 1 |
| Dai, HY; Duan, YY; Ji, XQ; Qin, DY; Xu, ZM; Zhang, CM; Zhang, JJ | 1 |
3 other study(ies) available for pyrrolidine dithiocarbamate and Endometrioma
| Article | Year |
|---|---|
Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways.
Topics: Animals; Antigens, CD34; Azo Compounds; Boronic Acids; Bortezomib; Case-Control Studies; Endometriosis; Eosine Yellowish-(YS); Female; Ki-67 Antigen; Methyl Green; NF-kappa B; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Pyrrolidines; Rats; Thiocarbamates | 2008 |
Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways.
Topics: Animals; Boronic Acids; Bortezomib; Endometriosis; Female; Mice; NF-kappa B; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Pyrrolidines; Thiocarbamates | 2009 |
Application of the nuclear factor-κB inhibitor pyrrolidine dithiocarbamate for the treatment of endometriosis: an in vitro study.
Topics: Antioxidants; Case-Control Studies; Cells, Cultured; Drug Evaluation, Preclinical; Endometriosis; Female; Gene Expression; Humans; Hyaluronan Receptors; Matrix Metalloproteinase 9; NF-kappa B; Ovarian Cysts; Peritoneal Diseases; Pyrrolidines; Stromal Cells; Thiocarbamates; Tissue Inhibitor of Metalloproteinase-1 | 2010 |